JP2006525368A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525368A5
JP2006525368A5 JP2006514250A JP2006514250A JP2006525368A5 JP 2006525368 A5 JP2006525368 A5 JP 2006525368A5 JP 2006514250 A JP2006514250 A JP 2006514250A JP 2006514250 A JP2006514250 A JP 2006514250A JP 2006525368 A5 JP2006525368 A5 JP 2006525368A5
Authority
JP
Japan
Prior art keywords
ligand
lipid
alkyl
independently
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006514250A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006525368A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/013727 external-priority patent/WO2004098524A2/en
Publication of JP2006525368A publication Critical patent/JP2006525368A/ja
Publication of JP2006525368A5 publication Critical patent/JP2006525368A5/ja
Pending legal-status Critical Current

Links

JP2006514250A 2003-05-02 2004-05-03 脂質白金錯体およびその使用方法 Pending JP2006525368A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46756703P 2003-05-02 2003-05-02
PCT/US2004/013727 WO2004098524A2 (en) 2003-05-02 2004-05-03 Lipid platinum complexes and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2006525368A JP2006525368A (ja) 2006-11-09
JP2006525368A5 true JP2006525368A5 (enExample) 2007-06-14

Family

ID=33435089

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006514250A Pending JP2006525368A (ja) 2003-05-02 2004-05-03 脂質白金錯体およびその使用方法

Country Status (6)

Country Link
US (1) US20070160656A1 (enExample)
EP (1) EP1622585A4 (enExample)
JP (1) JP2006525368A (enExample)
AU (1) AU2004235781A1 (enExample)
CA (1) CA2524478A1 (enExample)
WO (1) WO2004098524A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2525973A1 (en) * 2003-05-20 2004-12-09 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising capecitabine and a liposomal platinum complex
CA2526289A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising 5-fluorouracil or a derivative thereof and a liposomal platinum complex
CN1984663A (zh) 2004-03-29 2007-06-20 南佛罗里达大学 用曲西瑞宾和相关化合物有效治疗肿瘤和癌症
US20100009929A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
US20100173864A1 (en) 2004-03-29 2010-07-08 Cheng Jin Q Compositions including triciribine and one or more platinum compounds and methods of use thereof
GR20060100144A (el) * 2006-03-03 2007-10-17 Θεραπεια του καρκινου με χρηση οξαλιπλατινης εγκλεισμενης μεσα σε λιποσωματα και απο κοινου εγκλεισμος στο λιποσωμιακο μοριο περισσοτερων απο ενος φαρμακευτικου παρασκευασματος h gene
WO2008070136A1 (en) * 2006-12-06 2008-06-12 University Of South Florida Compositions including triciribine and one or more platinum compounds and methods of use thereof
EP2123258A1 (en) * 2008-05-23 2009-11-25 Liplasome Pharma A/S Liposomes for drug delivery
JP2012528846A (ja) * 2009-06-03 2012-11-15 マヨ、ジョン、チャールズ 深部組織の痛みを治療するための製剤
JP5860872B2 (ja) 2010-06-04 2016-02-16 オハイオ ユニバーシティー ホスファプラチン、及び癌治療のためのそれらの使用
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
CN103665050B (zh) * 2013-08-29 2016-04-27 西北工业大学 一种苯基咪唑邻菲罗啉竹红菌素铂配合物及其制备方法
US10744090B2 (en) 2015-06-30 2020-08-18 Sequessome Technology Holdings Limited Multiphasic compositions
CN105481902B (zh) * 2015-12-03 2017-12-05 昆明贵金属研究所 以磷酸二氢根为轴向配体的铂(iv)抗癌化合物
CN113453667A (zh) * 2018-11-02 2021-09-28 利帕克肿瘤学有限责任公司 脂质体增强腹腔内化学疗法
IL291110B2 (en) * 2019-09-05 2025-07-01 Vuab Pharma A S New platinum IV complexes with significantly enhanced antitumor activity
WO2021183588A1 (en) * 2020-03-10 2021-09-16 Chung Yuan Christian University Liposome composition and preparation method thereof
EP4139327A4 (en) * 2020-04-22 2024-10-02 Oncovolution, LLC PLATINUM PEPTIDE COMPLEXES AND METHODS OF USE THEREOF

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829957B2 (ja) * 1977-09-12 1983-06-25 喜徳 喜谷 新規な白金錯体
JPS5622724A (en) * 1979-08-02 1981-03-03 Asahi Chem Ind Co Ltd Pharmaceutical preparation of n4-acylcytosine arabinoside
EP0113508A1 (en) * 1982-11-04 1984-07-18 Inco Research & Development Center, Inc. Hydrophobic platinum compounds and their preparation
US5384127A (en) * 1985-10-18 1995-01-24 Board Of Regents, The University Of Texas System Stable liposomal formulations of lipophilic platinum compounds
US5041581A (en) * 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5117022A (en) * 1985-10-18 1992-05-26 The Board Of Regents, The University Of Texas System Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5902604A (en) * 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
AU7711096A (en) * 1996-12-03 1998-06-29 Rijsuniversiteit Utrecht Cisplatinum comprising pharmaceutical
US5843475A (en) * 1996-12-06 1998-12-01 Board Of Regents, The University Of Texas System Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes
EA002630B1 (ru) * 1997-02-05 2002-08-29 Фармация Энд Апджон Компани Способ получения липидных комплексов или липосом водонерастворимого диаминоциклогександикарбоксилата платины
AU2001277711A1 (en) * 2000-08-11 2002-02-25 Sumitomo Pharmaceuticals Co. Ltd. Remedies for cisplatin-tolerant cancer
AU2003258075A1 (en) * 2002-08-06 2004-02-23 Lyotropic Therapeutics, Inc. Lipid-drug complexes in reversed liquid and liquid crystalline phases

Similar Documents

Publication Publication Date Title
JP2005528325A5 (enExample)
JP2022124458A5 (enExample)
JP2023542944A5 (enExample)
JP2017538677A5 (enExample)
JP2005511699A5 (enExample)
JP2020530007A5 (enExample)
JP2013534248A5 (enExample)
JP2014510729A5 (enExample)
JP2009504763A5 (enExample)
JP2004533444A5 (enExample)
JP2019515908A5 (enExample)
JP2016506916A5 (enExample)
JP2015512860A5 (enExample)
JP2002517491A5 (enExample)
JP2006182786A5 (enExample)
JP2018135343A5 (enExample)
JP2016503414A5 (enExample)
JP2009530393A5 (enExample)
JP2018528273A5 (enExample)
JP2013538213A5 (enExample)
JP2023542945A5 (enExample)
JP2014523413A5 (enExample)
JP2007500222A5 (enExample)
PT701440E (pt) Complexos tri(platinicos)
KR890006228A (ko) 항종양제로서 폴리아민 유도체